OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer
Bharti Jaiswal, Akanksha Agarwal, Ashish Gupta
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 16

Showing 16 citing articles:

Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154

Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 19

Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
Fabio Raith, Daniel H. O’Donovan, Clara Lemos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2289-2289
Open Access | Times Cited: 23

SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis
Surbhi Chouhan, Dhivya Sridaran, Cody Weimholt, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Androgen receptor cofactors: A potential role in understanding prostate cancer
Xiang Li, Haojun Xiong, Xingzhu Mou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116338-116338
Open Access | Times Cited: 6

Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications
Lance Edward V. Lumahan, Mazia Arif, Amy E. Whitener, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 191-191
Open Access | Times Cited: 4

A narrative review of epigenetic marker in H3K27ac and its emerging potential as a therapeutic target in cancer
Meizi Zhu, Xuejin Lu, Danhong Wang, et al.
Epigenomics (2025), pp. 1-17
Closed Access

The epigenetic function of androgen receptor in prostate cancer progression
Takahiro Sawada, Yoshiaki Kanemoto, Tomohiro Kurokawa, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 8

Bio-Pathological Functions of Posttranslational Modifications of Histological Biomarkers in Breast Cancer
Anca-Narcisa Neagu, Claudiu-Laurentiu Josan, Taniya Jayaweera, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4156-4156
Open Access | Times Cited: 2

Histone acetyltransferases as promising therapeutic targets in glioblastoma resistance
Spoorthy Pathikonda, Farzane Amirmahani, Diya Mathew, et al.
Cancer Letters (2024), pp. 217269-217269
Open Access | Times Cited: 2

Unravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review
Charitomeni Gioukaki, Alexandros Georgiou, Lydia Evangelia Gkaralea, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11299-11299
Open Access | Times Cited: 5

Pangenomes of Human Gut Microbiota Uncover Links Between Genetic Diversity and Stress Response
Saar Shoer, Lee Reicher, Yitzhak Pilpel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Small-molecule TIP60 inhibitors enhance regulatory T cell induction through TIP60-P300 acetylation crosstalk
Francisco Fueyo‐González, Guillermo Vilanova, Mehek Ningoo, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108491-108491
Open Access | Times Cited: 2

Epigenomics, Transcriptomics, and Translational Control in Prostate Cancer
Gordana Kocić
Prostate Cancer (2024), pp. 89-121
Closed Access

Epigenetic (De)regulation in Prostate Cancer
Chenxi Xu, Shuai Zhao, Ling Cai
Cancer treatment and research (2023), pp. 321-360
Open Access

Page 1

Scroll to top